Neurological Disease News and Research

RSS

Quick formula could forecast which cancers chemo could kill

Researchers at the University of Rochester Medical Center have coined a simple formula that predicts how well a certain chemotherapy will work for targeting brain and other nervous system cancers. The formula, which publishes mid-July in Cancer Chemotherapy and Pharmacology, is pegged to two important proteins that compose such hard-to-kill tumors - one of which, ironically, makes them so drug-resistant in the first place.

15 Jul 2008

Novel approach for treating mitochondrial disorders wins Kaye prize

A novel concept for the treatment of mitochondrial disorders using directed enzyme replacement therapy (DERT) has won for a Hebrew University of Jerusalem doctoral candidate one of this year's Kaye Innovation Awards. The awards were presented at this year's 71st meeting of the Hebrew University Board of Governors.

30 Jun 2008

Subtle but detectable neurological abnormalities appear to predict risk of death in older individuals

Subtle but clinically detectable neurological abnormalities, such as reduced reflexes and an unstable posture, may be associated with the risk of death and stroke in otherwise healthy older adults, according to a report in the June 23 issue of Archives of Internal Medicine.

24 Jun 2008

Australian researchers find important piece of Alzheimer's puzzle

Queensland Brain Institute (QBI) neuroscientists at UQ have discovered a new way to reduce neuronal loss in the brain of a person with Alzheimer's disease.

11 Jun 2008

Turn up the lights and slow down dementia!

A team of Dutch scientists are suggesting that the progression of dementia can be significantly slowed down by treatments which reset the body's natural clock.

11 Jun 2008

Human stem cells show promise against fatal children's diseases

Scientists have used human stem cells to dramatically improve the condition of mice with a neurological condition similar to a set of diseases in children that are invariably fatal, according to an article in the June issue of the journal Cell Stem Cell.

4 Jun 2008

New insight into the genetics of Lou Gehrig's disease

An upcoming paper from Drs. Hidenori Ichijo and Hideki Nishitoh (The University of Tokyo) and colleagues lends new and valuable insight into the genetics of ALS.

1 Jun 2008

San Francisco Mayor rejects proposed budget cuts to HIV/AIDS services

San Francisco Mayor Gavin Newsom recently rejected proposed cuts to HIV/AIDS services in his fiscal year 2009 budget, the San Francisco Chronicle reports. According to the Chronicle, Newsom rejected a proposal by Mitch Katz, director of the San Francisco Department of Public Health, to cut $3 million of the $10 million the department allocates to 30 not-for-profit groups that provide HIV/AIDS services.

28 May 2008

A transgenic monkey model of Huntington's disease developed

Scientists have developed the first genetically altered monkey model that replicates some symptoms observed in patients with Huntington's disease, according to a new study funded by the National Institutes of Health. Researchers are now able to better understand this complex, devastating and incurable genetic disorder affecting the brain.

19 May 2008

New dimension discovered in body clock rhythm

Research on what makes the body clock tick has led Dr Michael Hastings of the MRC Laboratory of Molecular Biology in Cambridge to discover a new and unanticipated cog in the human body clock. A patent for the compound involved has been filed by MRC Technology. The results, published in Science, could lead to therapies for people whose sleep is disrupted by shift work or old age.

18 May 2008

microRNAs appear essential for retinal health

Retinas in newborn mice appear perfectly fine without any help from tiny bits of genetic material called microRNAs except for one thing - the retinas do not work.

7 May 2008

Enkephalin pathway shows potential as new target for Alzheimer's

Alzheimer's disease (AD) is an incurable disease that is increasing in prevalence and will increase even more rapidly as the Baby Boom generation enters the age of highest risk. The available AD drugs are only partially effective in some patients. New strategies are urgently needed.

7 May 2008

Brain tumor surgery, depression and survival

Depression is one of the most common psychiatric disorders in the world today. It is estimated that in any given year, 5 to 9 percent of the US population is clinically depressed. Studies have shown that depression negatively affects the immunological system, alters the body's response to malignancy, and may influence behavioral factors that impact recovery from disease

29 Apr 2008